Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Clinical trial NCT02462837 · TERMINATED

Trial details

NCT number: NCT02462837
Sponsor: Southern Illinois University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder, Overactive Pain Lower Urinary Tract Symptoms

Start date: 2015-05-01
Primary completion: 2019-01-30
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.